AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
95 hedge funds and large institutions have $195M invested in Accelerate Diagnostics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 25 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
35% less call options, than puts
Call options by funds: $1.13M | Put options by funds: $1.73M
Holders
95
Holding in Top 10
2
Calls
$1.13M
Puts
$1.73M
Top Buyers
| 1 | +$1.38M | |
| 2 | +$702K | |
| 3 | +$522K | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
+$428K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$417K |
Top Sellers
| 1 | -$3.26M | |
| 2 | -$1.11M | |
| 3 | -$706K | |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$698K |
| 5 |
Renaissance Technologies
New York
|
-$662K |